<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33359475</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2430</ISSN><JournalIssue CitedMedium="Internet"><Volume>337</Volume><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Experimental neurology</Title><ISOAbbreviation>Exp Neurol</ISOAbbreviation></Journal><ArticleTitle>Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous.</ArticleTitle><Pagination><StartPage>113576</StartPage><MedlinePgn>113576</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.expneurol.2020.113576</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0014-4886(20)30407-6</ELocationID><Abstract><AbstractText>The pathophysiology of Amyotrophic Lateral Sclerosis (ALS), a disease caused by the gradual degeneration of motoneurons, is still largely unknown. Insufficient neurotrophic support has been cited as one of the causes of motoneuron cell death. Neurotrophic factors such as BDNF have been evaluated in ALS human clinical trials, but yielded disappointing results attributed to the poor pharmacokinetics and pharmacodynamics of BDNF. In the inherited ALS G93A SOD1 animal model, deletion of the BDNF receptor TrkB.T1 delays spinal cord motoneuron cell death and muscle weakness through an unknown cellular mechanism. Here we show that TrkB.T1 is expressed ubiquitously in the spinal cord and its deletion does not change the SOD1 mutant spinal cord inflammatory state suggesting that TrkB.T1 does not influence microglia or astrocyte activation. Although TrkB.T1 knockout in astrocytes preserves muscle strength and co-ordination at early stages of disease, its specific conditional deletion in motoneurons or astrocytes does not delay motoneuron cell death during the early stage of the disease. These data suggest that TrkB.T1 may limit the neuroprotective BDNF signaling to motoneurons via a non-cell autonomous mechanism providing new understanding into the reasons for past clinical failures and insights into the design of future clinical trials employing TrkB agonists in ALS.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yanpallewar</LastName><ForeName>Sudhirkumar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neural Development Section, Mouse Cancer Genetics Program, CCR, NCI, NIH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fulgenzi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neural Development Section, Mouse Cancer Genetics Program, CCR, NCI, NIH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassoni-Ardori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neural Development Section, Mouse Cancer Genetics Program, CCR, NCI, NIH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrick</LastName><ForeName>Colleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neural Development Section, Mouse Cancer Genetics Program, CCR, NCI, NIH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessarollo</LastName><ForeName>Lino</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neural Development Section, Mouse Cancer Genetics Program, CCR, NCI, NIH, USA. Electronic address: tessarol@mail.nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA BC010391</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Neurol</MedlineTA><NlmUniqueID>0370712</NlmUniqueID><ISSNLinking>0014-4886</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C587672">IL1B protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C064371">Ntrk2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D020813">Receptor, trkB</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008262" MajorTopicYN="N">Macrophage Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020813" MajorTopicYN="N">Receptor, trkB</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Motoneuron degeneration</Keyword><Keyword MajorTopicYN="N">Neurotrophin</Keyword><Keyword MajorTopicYN="N">Receptor tyrosine kinase</Keyword><Keyword MajorTopicYN="N">Spinal cord inflammation</Keyword><Keyword MajorTopicYN="N">TrkB signaling</Keyword><Keyword MajorTopicYN="N">Truncated TrkB</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33359475</ArticleId><ArticleId IdType="mid">NIHMS1812804</ArticleId><ArticleId IdType="pmc">PMC9229840</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2020.113576</ArticleId><ArticleId IdType="pii">S0014-4886(20)30407-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Minton SK, Taves SR, Casper KB, Fiacco TA, McCarthy KD, 2008. What is the role of astrocyte calcium in neurophysiology? Neuron. 59, 932&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3623689</ArticleId><ArticleId IdType="pubmed">18817732</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, Naumann M, 2005. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph. Later. Scler. Other Motor Neuron Disord. 6, 100&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">16036433</ArticleId></ArticleIdList></Reference><Reference><Citation>Biffo S, Offenhauser N, Carter BD, Barde YA, 1995. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development. 121, 2461&#x2013;2470.</Citation><ArticleIdList><ArticleId IdType="pubmed">7671810</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Vande Velde C, Cleveland DW, 2006a. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 52, 39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW, 2006b. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 312, 1389&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahimi F, Galan A, Jmaeff S, Barcelona PF, De Jay N, Dejgaard K, Young JC, Kleinman CL, Thomas DY, Saragovi HU, 2020. Alternative splicing of a receptor intracellular domain yields different Ectodomain conformations, enabling isoform-selective functional ligands. iScience. 23, 101447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452315</ArticleId><ArticleId IdType="pubmed">32829283</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck CR, Seburn KL, Cope TC, 2000. Neurotrophin expression by spinal motoneurons in adult and developing rats. J. Comp. Neurol. 416, 309&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">10602090</ArticleId></ArticleIdList></Reference><Reference><Citation>Carim-Todd L, Bath KG, Fulgenzi G, Yanpallewar S, Jing D, Barrick CA, Becker J, Buckley H, Dorsey SG, Lee FS, Tessarollo L, 2009. Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J. Neurosci. 29, 678&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719435</ArticleId><ArticleId IdType="pubmed">19158294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao MV, Rajagopal R, Lee FS, 2006. Neurotrophin signalling in health and disease. Clin. Sci. 110, 167&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">16411893</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E, Cordiglieri C, Melli G, Newcombe J, Krumbholz M, Parada LF, Medico E, Hohlfeld R, Meinl E, Farina C, 2012. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J. Exp. Med. 209, 521&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302220</ArticleId><ArticleId IdType="pubmed">22393127</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey SG, Renn CL, Carim-Todd L, Barrick CA, Bambrick L, Krueger BK, Ward CW, Tessarollo L, 2006. In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron. 51, 21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16815329</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey SG, Lovering RM, Renn CL, Leitch CC, Liu X, Tallon LJ, Sadzewicz LD, Pratap A, Ott S, Sengamalay N, Jones KM, Barrick C, Fulgenzi G, Becker J, Voelker K, Talmadge R, Harvey BK, Wyatt RM, Vernon-Pitts E, Zhang C, Shokat K, Fraser-Liggett C, Balice-Gordon RJ, Tessarollo L, Ward CW, 2012. Genetic deletion of trkB.T1 increases neuromuscular function. Am. J. Phys. Cell Phys. 302, C141&#x2013;C153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328911</ArticleId><ArticleId IdType="pubmed">21865582</ArticleId></ArticleIdList></Reference><Reference><Citation>Drechsel DA, Estevez AG, Barbeito L, Beckman JS, 2012. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox. Res. 22, 251&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145402</ArticleId><ArticleId IdType="pubmed">22488161</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulgenzi G, Tomassoni-Ardori F, Babini L, Becker J, Barrick C, Puverel S, Tessarollo L, 2015. BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation. J. Cell Biol. 210, 1003&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576863</ArticleId><ArticleId IdType="pubmed">26347138</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulgenzi G, Hong Z, Tomassoni-Ardori F, Barella LF, Becker J, Barrick C, Swing D, Yanpallewar S, Croix BS, Wess J, Gavrilova O, Tessarollo L, 2020. Novel metabolic role for BDNF in pancreatic beta-cell insulin secretion. Nat. Commun. 11, 1950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181656</ArticleId><ArticleId IdType="pubmed">32327658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel C, Gotz R, Lorrain A, Sendtner M, 1997. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat. Med. 3, 765&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">9212104</ArticleId></ArticleIdList></Reference><Reference><Citation>Group BS, 1999. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF study group (phase III). Neurology. 52, 1427&#x2013;1433.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227630</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Pang K, Chen Y, Wang S, Li H, Xu Y, Han F, Yao H, Liu H, Lopes-Rodrigues V, Sun D, Shao J, Shen J, Dou Y, Zhang W, You H, Wu W, Lu B, 2019. TrkB agonistic antibodies superior to BDNF: utility in treating motoneuron degeneration. Neurobiol. Dis. 132, 104590.</Citation><ArticleIdList><ArticleId IdType="pubmed">31470106</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Schneider A, 2010. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front. Neurosci. 4, 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902233</ArticleId><ArticleId IdType="pubmed">20592948</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt LM, Hernandez RD, Pacheco NL, Torres Ceja B, Hossain M, Olsen ML, 2019. Astrocyte morphogenesis is dependent on BDNF signaling via astrocytic TrkB. T1. Elife 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726422</ArticleId><ArticleId IdType="pubmed">31433295</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang EJ, Reichardt LF, 2001. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758233</ArticleId><ArticleId IdType="pubmed">11520916</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang EJ, Reichardt LF, 2003. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">12676795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Klinkosz B, Greene T, Cedarbaum JM, Wong V, Lindsay RM, Mitsumoto H, 1995. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol. 37, 505&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">7717687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyachandran A, Mertens B, McKissick EA, Mitchell CS, 2015. Type I vs. type II cytokine levels as a function of SOD1 G93A mouse amyotrophic lateral sclerosis disease progression. Front. Cell. Neurosci. 9, 462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664727</ArticleId><ArticleId IdType="pubmed">26648846</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephson A, Widenfalk J, Trifunovski A, Widmer HR, Olson L, Spenger C, 2001. GDNF and NGF family members and receptors in human fetal and adult spinal cord and dorsal root ganglia. J. Comp. Neurol. 440, 204&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">11745618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, Genge A, Arnold DL, 2003. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph. Later. Scler. Other Motor Neuron Disord. 4, 22&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12745614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan DR, Miller FD, 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851172</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JS, Barohn RJ, Dimachkie MM, Mitsumoto H, 2015. The dilemma of the clinical Trialist in amyotrophic lateral sclerosis: the hurdles to finding a cure. Neurol. Clin. 33, 937&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">26515630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, Ng SK, Diaz N, Burstein S, Morel L, Osgood A, Sider B, Higashimori H, Haydon PG, Manfredi G, Yang Y, 2014. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 34, 2331&#x2013;2348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishino A, Ishige Y, Tatsuno T, Nakayama C, Noguchi H, 1997. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp. Neurol. 144, 273&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">9168829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kust BM, Copray JC, Brouwer N, Troost D, Boddeke HW, 2002. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp. Neurol. 177, 419&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">12429188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JC, Tsao D, Barras P, Bastarrachea RA, Boyd B, Chou J, Rosete R, Long H, Forgie A, Abdiche Y, Dilley J, Stratton J, Garcia C, Sloane DL, Comuzzie AG, Rosenthal A, 2008. Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One 3, e1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2270901</ArticleId><ArticleId IdType="pubmed">18382675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Nagappan G, Guan X, Nathan PJ, Wren P, 2013. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat. Rev. Neurosci. 14, 401&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">23674053</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH, 2019. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 137, 715&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkouris S, Barde YA, Binley KE, Allen ND, Stepanov AV, Wu NC, Grande G, Lin CW, Li M, Nan X, Chacon-Fernandez P, DiStefano PS, Lindsay RM, Lerner RA, Xie J, 2018. Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library. Proc. Natl. Acad. Sci. U. S. A. 115, E7023&#x2013;E7032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065019</ArticleId><ArticleId IdType="pubmed">29987039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JD, Borasio GD, 2007. Amyotrophic lateral sclerosis. Lancet. 369, 2031&#x2013;2041.</Citation><ArticleIdList><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse JK, Wiegand SJ, Anderson K, You Y, Cai N, Carnahan J, Miller J, DiStefano PS, Altar CA, Lindsay RM, et al., 1993. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13, 4146&#x2013;4156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576390</ArticleId><ArticleId IdType="pubmed">8080477</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Sobue G, Hamano T, Kuriyama M, Hirayama M, Yamamoto M, Mitsuma T, 2000. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem. Res. 25, 239&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">10786708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J, 2018. ALS genes in the genomic era and their implications for FTD. Trends Genet. 34, 404&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikodemova M, Small AL, Smith SM, Mitchell GS, Watters JJ, 2014. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats. Neurobiol. Dis. 69, 43&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079765</ArticleId><ArticleId IdType="pubmed">24269728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV, 2000. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Later. Scler. Other Motor Neuron Disord. 1, 201&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464953</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian MD, Zhang J, Tan XY, Wood A, Gill D, Cho S, 2006. Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. J. Neurosci. 26, 9394&#x2013;9403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674613</ArticleId><ArticleId IdType="pubmed">16971523</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarta E, Fulgenzi G, Bravi R, Cohen EJ, Yanpallewar S, Tessarollo L, Minciacchi D, 2018. Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice. Mol. Cell. Neurosci. 89, 33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108068</ArticleId><ArticleId IdType="pubmed">29580900</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, Konnerth A, 2003. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature. 426, 74&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">14603320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA, 1992. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 360, 757&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pubmed">1465147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H, Chen M, Pang D, Xia X, Du C, Yang W, Cui Y, Huang C, Jiang W, Bi D, Li C, Shang H, Worley PF, Xiao B, 2020. LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice. Cell Death Differ. 27, 1369&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206132</ArticleId><ArticleId IdType="pubmed">31570855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessarollo L, 1998. Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev. 9, 125&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">9754707</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoenen H, Sendtner M, 2002. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5 (Suppl), 1046&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pubmed">12403983</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd D, Gowers I, Dowler SJ, Wall MD, McAllister G, Fischer DF, Dijkstra S, Fratantoni SA, van de Bospoort R, Veenman-Koepke J, Flynn G, Arjomand J, Dominguez C, Munoz-Sanjuan I, Wityak J, Bard JA, 2014. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington&#x2019;s disease. PLoS One 9, e87923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913682</ArticleId><ArticleId IdType="pubmed">24503862</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomassoni-Ardori F, Fulgenzi G, Becker J, Barrick C, Palko ME, Kuhn S, Koparde V, Cam M, Yanpallewar S, Oberdoerffer S, Tessarollo L, 2019. Rbfox1 up-regulation impairs BDNF-dependent hippocampal LTP by dysregulating TrkB isoform expression levels. Elife. 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715404</ArticleId><ArticleId IdType="pubmed">31429825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar YRLB, Ramirez-Jarquin UN, Lazo-Gomez R, Tapia R, 2014. Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy. Front. Cell. Neurosci. 8, 61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937589</ArticleId><ArticleId IdType="pubmed">24616665</ArticleId></ArticleIdList></Reference><Reference><Citation>Traub S, Stahl H, Rosenbrock H, Simon E, Florin L, Hospach L, Horer S, Heilker R, 2017. Pharmaceutical characterization of tropomyosin receptor kinase B-agonistic antibodies on human induced pluripotent stem (hiPS) cell-derived neurons. J. Pharmacol. Exp. Ther. 361, 355&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">28351853</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Ackerley S, Davies KE, Talbot K, 2010. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Hum. Mol. Genet. 19, 815&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese S, Jablonka S, Holtmann B, Orel N, Rajagopal R, Chao MV, Sendtner M, 2007. Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc. Natl. Acad. Sci. U. S. A. 104, 17210&#x2013;17215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2040418</ArticleId><ArticleId IdType="pubmed">17940030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Li L, Yick LW, Chai H, Xie Y, Yang Y, Prevette DM, Oppenheim RW, 2003. GDNF and BDNF alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats. J. Neurotrauma 20, 603&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">12906744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Q, Elliott J, Snider WD, 1992. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360, 753&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">1281520</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L, 2012. Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One 7, e39946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3384607</ArticleId><ArticleId IdType="pubmed">22761934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Huang EJ, 2006. Dynamic expression of neurotrophic factor receptors in postnatal spinal motoneurons and in mouse model of ALS. J. Neurobiol. 66, 882&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3600432</ArticleId><ArticleId IdType="pubmed">16680759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou YH, Guan PP, Zhang SQ, Guo YS, Wang P, 2020. Rofecoxib attenuates the pathogenesis of amyotrophic lateral sclerosis by alleviating Cyclooxygenase-2-mediated mechanisms. Front. Neurosci. 14, 817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438558</ArticleId><ArticleId IdType="pubmed">32903591</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>